US4839366A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methylthioquinolyl guanidine derivative, process of preparation thereof and pharmaceutical compositions therefrom
Assignee: Chiesi Farmaceutici SpA
•
Filing: 1988-02-23
•
Granted: 1989-06-13
•
Expires: 2008-02-23
Abstract
Abstract The compound of formula (I): ##STR1## N-cyclohexyl-N"-4-(2-methylthioquinolyl)-N'-2-thiazolyl-guanidine and pharmaceutically acceptable salts thereof is a valuable antiinflammatory, analgesic and antipyretic agent. The compound of the invention may be formulated with conventional pharmaceutically acceptable carriers or diluents to provide a pharmaceutical composition.
Inventors
- 👤 Giuseppe Quadro
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 08:24
CPC Classifications
C; C07; C07D; C07D417/00; C07D417/02; C07D417/12; A; A61; A61P; A61P25/00; A61P25/04; A61P29/00; A61P43/00; C07C; C07C331/00; C07C331/16; C07C331/28; C07C65/00; C07C65/21; C07D209/00; C07D209/02; C07D209/04; C07D209/30; C07D209/32; C07D209/38; C07D215/00; C07D215/02; C07D215/16; C07D215/38; C07D215/42; C07D215/46; C07D215/48; C07D215/50
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
6 words
The compound N-cyclohexyl-N"-4-(2-methylthioquinolyl)-N'-2-thiazolyl-guanidine of formula ##STR5##
Claim 2
Dependent Claim
6 words
The compound N-cyclohexyl-N"-4-(2-methylthioquinolyl)-N'-2-thiazolyl-guanidine of formula ##STR5##
Claim 3
Dependent Claim
35 words
A pharmaceutical composition having antiinflammatory, analgesic, antipyretic activity containing as active component a therapeutically effective amount of the compound having formula I ##STR6## or a non-toxic salt thereof and a pharmaceutically acceptable carrier or diluent.
Claim 4
Dependent Claim
35 words
A pharmaceutical composition having antiinflammatory, analgesic, antipyretic activity containing as active component a therapeutically effective amount of the compound having formula I ##STR6## or a non-toxic salt thereof and a pharmaceutically acceptable carrier or diluent.
Claim 5
Dependent Claim
35 words
A pharmaceutical composition according to claim 2 for oral, rectal or parenteral administration, in the form of capsules, tablets, suppositories or vials, containing from 100 to 500 mg of said active component per unit dose.
Claim 6
Dependent Claim
27 words
A pharmaceutical composition according to claim 2 for topical administration in form of a cream, ointment or gel containing from 1% to 5% of said active component.
References Cited (Backward Citations)
US4293549A
Cited
US4680300A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-06-12 | 1992-12-12 | 1993-06-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-06-12 | 1996-12-12 | 1997-06-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-06-12 | 2000-12-12 | 2001-06-13 | $7700.00 | Window Closed / Lapsed |